Mather Group’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$5.3K Buy
+145
New +$5.26K ﹤0.01% 1802
2025
Q1
– Sell
-13
Closed -$154 – 1850
2024
Q4
$154 Buy
+13
New +$154 ﹤0.01% 1711

Other funds holding ROIV

Mather Group's ROIV Position: Q3 2026 in Review

Mather Group opened a new position in Roivant Sciences (ROIV) in Q3 2026: 145 shares worth $5.3K. The stake represents ﹤0.01% of the portfolio and ranks #1802 among its holdings. This is a return to the name: Mather Group previously reported a position in ROIV as recently as Q4 2024.

Mather Group first reported a position in ROIV in Q4 2024 and has held it in 2 quarters since. 93 funds tracked by Wall St. Rank hold ROIV as of Q3 2026.

  • Mather Group held 145 shares of Roivant Sciences worth $5.3K as of Q3 2026.
  • Roivant Sciences was a new Mather Group position in Q3 2026.
  • Roivant Sciences made up ﹤0.01% of Mather Group's portfolio in Q3 2026, its #1802 holding.
  • Mather Group first reported a position in Roivant Sciences in Q4 2024 and has held it in 2 quarters since.
  • 93 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2026.

Based on Mather Group's 13F filing for Q3 2026, filed 14 Oct 2026.